Search results
Author(s):
Angelo Auricchio
,
Anne B Curtis
Added:
4 months ago
Prof Anne Curtis (University of Buffalo, US) and Prof Angelo Auricchio (Fondazione Cardiocentro Ticino, CH) discuss contemporary clinical data of Implantable Cardioverter Defibrillators (ICDs) from real world populations. The discussion is focused on the importance and impact of ICD therapy on prevention of sudden cardiac death by analysing the latest presented data.In context, the data analysed…
View more
Author(s):
Ahmadreza Karimianpour
,
Leah John
,
Michael R Gold
Added:
2 years ago
Author(s):
Roberto Rordorf
Added:
1 year ago
Author(s):
Joshua R Silverstein
,
Demosthenes G Katritsis
,
Mark E Josephson
Added:
3 years ago
Sudden cardiac death (SCD) is one of the leading causes of death in developed countries. The yearly incidence of SCD is estimated to be 3,000,000 worldwide and between 300,000–450,000 in both the US and Western Europe.1,2 The survival rate for SCD is <1 % worldwide and close to 5 % in the developed world.3 In the past, cardiac arrest was thought to be most commonly due to ventricular…
View more
Author(s):
Deepika Narasimha
,
Anne B Curtis
Added:
3 years ago
Implantable cardiac devices such as implantable cardioverter- defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) devices lead to improved survival and better clinical outcomes in appropriately selected patients with heart failure (HF) with a reduced ejection fraction (EF). Although there are significant sex differences in the aetiology, pathophysiology and clinical course of HF,…
View more
Author(s):
Andrei D Mărgulescu
,
Mark H Anderson
Added:
3 years ago
Motor vehicle travel and driving has become a major component of daily living in the developed world. Sudden incapacity occurring while driving can result in accidents that may be fatal both for the driver and for bystanders. The regulatory approach aims to balance the risk to bystanders against the highly valued individual freedom of motorised mobility. In this article we review some of the…
View more
Author(s):
Pier D Lambiase
Added:
2 years ago
Prof Pier Lambiase (UCL & Barts Heart Centre, London, UK) discusses the long-term efficacy and final outcomes of the subcutaneous implantable cardioverter-defibrillator (S-ICD) registry. The registry was conducted at 50 centres worldwide, in patients requiring an ICD for the treatment of ventricular tachyarrhythmias.
Questions
1. What are the benefits of S-ICDs compared to ICDs?
2. What is the S…
View more
Author(s):
Charles D Swerdlow
Added:
3 years ago
Balanced Evaluation of the ICD
Although better known for his transformative contributions to arrhythmia mechanisms, mapping and ablation, Dr Josephson participated in investigational studies of the first implantable defibrillator2,3 and served as a principal investigator for the MUSTT (Multicenter Unsustained Tachycardia Trial) foundational trial of primary-prevention ICD therapy.4 In one of the…
View more
Digital Health: New Cardiac Implantable Devices & App Based Solutions to Increase Clinic Efficiency
Author(s):
Enrico Caiani
,
Paul Roberts
,
Martin R Cowie
Start date:
Jun 06, 2019
Broadcast
Matt Swift
Job title: Cardiac Physiologist
Author